TABLE 1.
Demographic and clinical characteristics (n = 152) stratified by MoCA score
| Demographics | MoCA >24 (n = 85) | MoCA ≤24 (n = 67) | p‐value |
|---|---|---|---|
| Age (years), mean ± SD | 58.93 ± 15.34 | 70.79 ± 11.48 | <0.001 |
| Educational level ≤12 years, n (%) | 40 (47.1) | 56 (83.6) | <0.001 |
| Sex m/f, n (%) | 56 (65.9)/29 (34.1) | 50(74.6)/17(25.4) | 0.244 |
| Comorbidities | |||
| Arterial hypertension, n (%) | 80 (94.1) | 64 (95.5) | 0,700 |
| Diabetes mellitus, n (%) | 19 (22.4) | 29 (43.3) | 0.006 |
| Hypercholesterolemia, n (%) | 46 (54.1) | 46 (68.7) | 0.069 |
| Nicotine abuse, n (%) | 22 (25.9) | 8 (11.9) | 0.032 |
| BMI, mean ± SD | 25.50 ± 5.61 | 26.45 ± 5.42 | 0.161 |
| Aetiology of ESRD | |||
| Diabetic nephropathy, n (%) | 8 (9.4) | 12 (17.9) | 0.124 |
| Hypertensive nephropathy, n (%) | 5 (5.9) | 11 (16.4) | 0.036 |
| Glomerulonephritis, n (%) | 25 (29.4) | 15 (22.4) | 0.329 |
| Other causes, n (%) | 35 (41.2) | 18 (26.9) | 0.066 |
| Unknown, n (%) | 12 (14.1) | 11 (16.4) | 0.694 |
| Dialysis‐specific data | |||
| Dialysis vintage (months), mean ± SD | 70.34 ± 69.08 | 55.32 ± 56.22 | 0.190 |
| Ultrafiltration volume (liters), mean ± SD | 2.21 ± 1.11 | 2.40 ± 1.02 | 0.292 |
| Microcirculatory function ‐ DVA | |||
| aMax | 2.2 ± 2.5 | 1.6 ± 2.1 | 0.172 |
| vMax | 3.6 ± 2.4 | 2.9 ± 2.0 | 0.024 |
Abbreviations: aMax: maximum arteriolar dilation; DVA: dynamic vessel analysis, ESRD: end stage renal disease, m/f: male/female, vMax: maximum venular dilation.